5 new weight-loss drugs to watch in fight for next Ozempic
Lost and found: Life after Ozempic and other weight-loss drugs was just the start for these four people
Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage chronic conditions such as diabetes and heart disease and others to help them lose weight.
GLP-1 drugs have been linked to numerous potential health benefits like treatment of existing conditions including heart ...
The blockbuster drugs Ozempic and Wegovy may help people cut back on drinking, new research published Wednesday in JAMA ...
The weight loss drugs Ozempic and Wegovy may be beneficial for people struggling with alcohol addiction, a study published ...
Other side effects include 7,228 reports of nausea, vomiting, and diarrhoea linked to the use of weight loss jabs such as ...
13don MSN
Novo Nordisk, the pharma giant behind Ozempic and Wegovy, has surprising love story origins. The founders, a married couple, ...
Susan McGowan died on September 4. Obesity in an ageing population 'is biggest issue for the NHS' Wegovy, Ozempic, weight loss - and the future of obesity Junk food crackdown 'would slash obesity ...
A recent study conducted in Sweden found that GLP-1 agonists such as Ozempic and Wegovy may help reduce alcohol consumption and related harms in individuals diagnosed with alcohol use disorder. Here ...
13don MSN
Novo Nordisk scientist Lotte Knudsen, whose research led to Ozempic and Wegovy, started her career developing laundry ...
As a new study finds that people who stopped taking semaglutide, the active ingredient in the new blockbuster weight loss ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback